Here we evaluated the ability of GSK461364 to inhibit neuroblastoma cell viability and proliferation and to induce death in cell lines with different MYCN copy number backgrounds, and to suppress xenograft tumor growth in nude mice. This evidence concerns the gene MYCN and neuroblastoma.